Muscular dystrophy, myasthenia gravis, Eaton-Lambert syndrome, amyotrophic lateral sclerosis, or mitochondrial disease

Uncontrolled epilepsy

Botulinum Toxin therapy of any serotype for any condition within the last 6 months

History of surgical intervention of the lower study leg or planned surgery of any limb during the study

Previous casting of the study limb for spasticity within 6 months or with a dynamic splint within 3 months, or planned casting or dynamic splinting for spasticity of the study limb or affected upper limb during the study

BOTOX® Treatment in Pediatric Lower Limb Spasticity

What this study is about